Candesant Biomedical

San Francisco, United States

Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis.

$35.0M raised

Jun 2023

Series B

Health Care Medical Medical Device

Top Investors

Polaris Partners Correlation Ventures Astia KCK Medtech

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Candesant Biomedical

How much funding has Candesant Biomedical raised?

Candesant Biomedical has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in June 2023.

Who are Candesant Biomedical's investors?

Candesant Biomedical's investors include Polaris Partners, Correlation Ventures, Astia, KCK Medtech.

Where is Candesant Biomedical headquartered?

Candesant Biomedical is headquartered in San Francisco, United States.

What does Candesant Biomedical do?

Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis.

What stage is Candesant Biomedical at?

Candesant Biomedical is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 6, 2023.

MLA

"Candesant Biomedical — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/candesant-biomedical. Accessed July 3, 2026.

APA

VCBacked. (2023). Candesant Biomedical — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/candesant-biomedical

Wikipedia (cite web)

{{cite web |title=Candesant Biomedical — Funding & Investors |url=https://www.vcbacked.co/company/candesant-biomedical |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 6, 2023.

Similar Companies in Health Care

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Circl Brain Health Metrics

Victoria$354K

YLAH

Bern$589K